Publication | Open Access
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
256
Citations
40
References
2022
Year
ChiCTR1900026240.
| Year | Citations | |
|---|---|---|
Page 1
Page 1